Wire flash
J&J in Talks to Sell Hips-and-Knees Business to Apollo for $20 Billion
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Johnson & Johnson (J&J) is reportedly in negotiations to sell its hips-and-knees orthopedic business to private equity firm Apollo Global Management for approximately $20 billion. The deal, if completed, would represent a significant divestiture for J&J as it focuses on higher-growth areas like medical devices and pharmaceuticals. The information comes from a Yahoo Finance article summarizing the report, which cites sources familiar with the matter. The sale price and the identity of the buyer are central to the report, though the talks are ongoing and may not result in a finalized agreement.
Source report
Johnson & Johnson (J&J) is in discussions to sell its hips-and-knees surgical business to private equity firm Apollo Global Management for approximately $20 billion, according to sources familiar with the matter.
Deal Overview
- Seller: Johnson & Johnson
- Buyer: Apollo Global Management
- Estimated Value: $20 billion
- Business Unit: Hips-and-knees surgical business
Context
The potential transaction represents a significant divestiture for J&J as it continues to reshape its portfolio. The hips-and-knees business is part of J&J's medical devices segment, which focuses on orthopedic implants and surgical products.
Apollo, a major private equity firm, is reportedly in advanced talks to acquire the unit, though the deal has not been finalized and terms could still change.
Source
Yahoo FinanceWestern
Part of this Story
Apollo Global in talks to acquire Johnson & Johnson’s DePuy Synthes unit for $20 billion